Keyphrases
Plasmodium Falciparum
100%
Malaria Vaccine
100%
Genetic Polymorphism
100%
Reticulocyte Binding Protein
100%
Lagos Nigeria
100%
T Cell Epitope
30%
Polypeptide
23%
B-cell Epitope
23%
MHC Class II
15%
PfRH5
15%
Intrinsically Unstructured Region
15%
High-affinity Binding
15%
Vaccine Development
15%
Paucity
7%
Evolutionary Relationship
7%
Malaria
7%
Sequence Method
7%
Amino Acids
7%
Phylogenetic Analysis
7%
Parasite Survival
7%
Tyrosine
7%
Polymorphism
7%
Population Genetic Differentiation
7%
Field Isolates
7%
Erythrocyte Invasion
7%
Nigerian Isolates
7%
Genetic Variation
7%
Nonsynonymous
7%
SNP-Single nucleotide Polymorphism
7%
Sterile Immunity
7%
Vaccine Candidate
7%
Direction Selectivity
7%
Strain Specificity
7%
Cross-protective
7%
5 Gene
7%
Synonymous mutation
7%
Multicomponent Vaccine
7%
Balancing Selection
7%
Cysteine
7%
Merozoite
7%
Bi-directional Sequencing
7%
Anti-disease
7%
Prospective Cross-sectional Study
7%
Genetic Diversity
7%
Interpopulation
7%
Common Haplotype
7%
Next-generation Vaccines
7%
Immunology and Microbiology
Protein Binding
100%
Reticulocyte
100%
Genetic Polymorphism
100%
Plasmodium falciparum
100%
Epitope
45%
T Cell
36%
B Cell
27%
Haplotype
27%
Binding Affinity
18%
Single Nucleotide Polymorphism
18%
Genetic Variability
18%
Major Histocompatibility Complex
18%
Phylogeny
9%
Parasite Survival
9%
Balancing Selection
9%
Directional Selection
9%
Erythrocyte
9%
Merozoite
9%
Genetic Variation
9%
House Dust Mite Allergen Extract
9%
Immunology
9%
Evolution
9%
Cladistics
9%
Biochemistry, Genetics and Molecular Biology